IMI10: cancer immunotherapy Flashcards
what is immunotherapy?
unique approach aimed at defeating cancer
designed to instruct the body’s own immune system to kill off the patient’s own cancer cells in the same way it does with other foreign invaders such as bacteria
what cells are immunosuppressive?
regulatory T cells and certain types of myeloid cells
what are the characteristics of immunotherapy?
specific
adaptable
durable
what’re the different types of cancer immunotherapies?
active and passive
what s an active immunotherapy? what are the 2 active immunotherapies?
aims to trigger an anti tumour response from eh immune system of the patient
cytokine therapy
cancer vaccines
what s a passive immunotherapy? what are the 2 passive immunotherapies?
requires the use of biological reagents such as mAbs or antigen-specific adaptive immune cells
monoclonal antibody therapy
cell-based therapy
what are the different drawbacks and limitations of cytokine therapy?
side effects like flu-like symptoms, depression and fatigue
short half-life
amount of cytokines: expressing sufficient amounts of cytokines int he appropriate target cells
what is adjunctive therapy?
additional therapy that is used with the primary therapy with the objective of enhancing the primary therapy
what are cancer vaccines?
type of vaccines that are designed to boost your immune system to protect you against tumours such as cervical, prostate and bladder cancers
what are the different type of cancer vaccines?
antigen vaccines
DC vaccines
DNA-RNA vaccines
tumour cell vaccines
should the vaccine be used before or after a patient develops a tumour?
depends on what we are looking to achieve
if we want to protect a patient before they dev a tumour–> prophylactic vaccine
if we want to help the immune system of the patient after being diagnosed with cancer–>therapeutic vaccine
what do prophylactic vaccines do?
provide prior immunity so that the body can build up tumour-specific antibodies or T cells without counteracting illness
what are the 2 groups of therapeutic vaccines?
autologous cancer vaccines
allogeneic cancer vaccines
what are the drawbacks of cancer vaccines?
hostiles tumour microenvironment
tumour escape
older or sick people can have a weaker immune system?
what are the 2 types of cancer prophylactic vaccines?
HPV vaccine
hepatitis B vaccine
what are monoclonal antibodies designed for?
designed against antigens presented on the surface of tumour cells
what are the different types of monoclonal antibodies?
naked mAbs
conjugated mAbs
bispecific mAbs
how do naked mAbs work?
different ways:
- can improve the immune response against cancer cells y attaching to the tumour cells and marking them for the immune system to kill them through antibody-dependent cell mediated cytotoxicity (ADCC) which lead to cell lysis via effector immune cells such as NK cells, eosinophils, macrophages or neutrophils
- can bind to and inhibit proteins on cancer cells or on other nearby cells that are necessary for the cancer cells to grow or spread
- can increase the immune response by targeting immune checkpoints such as anti-PD1/anti-PDL1
what are conjugated mAbs?
ab attached to a radioactive particle or to a chemotherapy drug that is used as a shuttle to deliver these substances more specifically to cancer cells?
what are the different types of conjugated mAbs?
radio-labelled abs
chemo-labelled abs
what are bispecific mAbs designed for?
designed as an antibody that is composed of two different mAbs and can bind 2 different antigens simultaneously which allows them to bring together or cluster the cancer cells and immune cells which facilitates the immune cells to attack the cancer cells
what are the drawbacks of mAbs therapy?
allergic reactions
production costs
tissue penetration
mode of action
what is cellular based therapy?
relies on immune cells derived straight from the patient which are modified in the lab to enhance the recognition and killing of the patients own tumour cells
what are different types of cell-based therapy?
tumour infiltrating lymphocytes (TILs) with IL-2
genetically modified cytotoxic T cells
what are drawbacks of cell-based therapy?
side effects manufacturing process in vivo efficacy antigen loss hostile tumour microenvironment